MELISSA HALE: Open Payments
NPI 1063640985 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 12 payments from 7 companies in 2025. Trend: 2023 $236 · 2024 $242 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $40 |
| Indivior Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: BRIXADI, VIVITROL, SUBLOCADE, VRAYLAR, HETLIOZ, CAPLYTA, RELISTOR.
Industry payments across KY — which companies pay providers there.
